iZafe Group AB (FRA:M02) FCF Margin %: -192.00% (As of Mar. 2026)


FRA:M02 iZafe Group AB FRA:M02
48 GF Score
Price €0.03
GF Value €0.04
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is iZafe Group AB FCF Margin %?

iZafe Group AB FRA:M02 -5.06% 48 FCF Margin % is -192.00% as of Mar. 2026. GuruFocus rates FRA:M02 with a GF Score™ of 48/100 and a GF Value™ of €0.04 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, iZafe Group AB ranks worse than 86.99% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. iZafe Group AB's Free Cash Flow for the three months ended in Mar. 2026 was €-0.43 Mil. iZafe Group AB's Revenue for the three months ended in Mar. 2026 was €0.23 Mil. Therefore, iZafe Group AB's FCF Margin % for the quarter that ended in Mar. 2026 was -192.00%.

As of today, iZafe Group AB's current FCF Yield % is -8.41%.

The historical rank and industry rank for iZafe Group AB's FCF Margin % or its related term are showing as below:

FRA:M02' s FCF Margin % Range Over the Past 10 Years
Min: -7626.02   Med: -316.59   Max: -136.02
Current: -171.93

During the past 13 years, the highest FCF Margin % of iZafe Group AB was -136.02%. The lowest was -7626.02%. And the median was -316.59%.

FRA:M02's FCF Margin % is ranked worse than
86.99% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.1 vs FRA:M02: -171.93

iZafe Group AB FCF Margin % Related Terms

iZafe Group AB FCF Margin % Historical Data

* Premium members only.

The historical data trend for iZafe Group AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iZafe Group AB FCF Margin % Chart

iZafe Group AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7,632.56 -3,324.24 -696.93 -160.06 -253.90

iZafe Group AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -533.33 -151.46 -263.00 -120.54 -192.00

FRA:M02 vs ISRG, BDX, MDLN: FCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, iZafe Group AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iZafe Group AB FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iZafe Group AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where iZafe Group AB's FCF Margin % falls into.


FRA:M02
48GF Score
iZafe Group AB FRA:M02
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iZafe Group AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

iZafe Group AB's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.399/0.551
=-253.90 %

iZafe Group AB's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.432/0.225
=-192.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -192.00% mean?
iZafe Group AB (FRA:M02) has a FCF Margin % of -192.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on iZafe Group AB and its competitors. According to the industry distribution chart, iZafe Group AB ranks #709 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 87%.
Is iZafe Group AB's FCF Margin % too high?
iZafe Group AB's current FCF Margin % is -192.00%. Based on the distribution chart, iZafe Group AB ranks #709 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, iZafe Group AB has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iZafe Group AB's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, iZafe Group AB ranks #709 out of 815 companies for FCF Margin %. This places iZafe Group AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on iZafe Group AB and its competitors. iZafe Group AB's current FCF Margin % is -192.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iZafe Group AB stock overvalued right now?
Based on GuruFocus' analysis, iZafe Group AB (FRA:M02) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.04, compared to a current price of €0.03 — trading 15.5% below its estimated fair value. The current FCF Margin % is -192.00%. iZafe Group AB's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For iZafe Group AB (FRA:M02), the current FCF Margin % is -192.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iZafe Group AB (FRA:M02) Overvalued in 2026?

Based on GuruFocus' analysis, iZafe Group AB stock appears to be undervalued. The current stock price of €0.03 is trading 15.5% below its estimated GF Value™ of €0.04. GuruFocus considers iZafe Group AB to be Modestly Undervalued.

Key valuation signals for FRA:M02:

  • FCF Margin %: -192.00%
  • GF Value™: €0.04 vs. price of €0.03 (15.5% below fair value)
  • GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the FRA:M02 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iZafe Group AB Business Description

Other Exchanges IZAFE B:Sweden
Address David Bagares Gata 3, Stockholm, SWE, 111 38
iZafe Group AB is a Developer of a digital medication dispensing system designed to enhance patient safety and reduce medication errors in home healthcare. The company offers a smart medication robot with automated dispensing and remote monitoring, enabling public and private healthcare providers in Sweden, the Nordics, and international markets, improved treatment adherence and reduced caregiver workload.
48GF Score

Get the complete analysis for FRA:M02

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.04
GF Value